ABSTRACT
Acne vulgaris, rosacea, and hidradenitis suppurativa are enduring inflammatory skin conditions that frequently manifest with akin clinical attributes, posing a considerable challenge for their distinctive diagnosis. While these conditions do exhibit certain resemblances, they also demonstrate distinct underlying pathophysiological mechanisms and treatment modalities. Delving into both the molecular parallels and disparities among these three disorders can yield invaluable insights for refined diagnostics, effective management, and targeted therapeutic interventions. In this report, we present a comparative analysis of transcriptomic data across these three diseases, elucidating differentially expressed genes and enriched pathways specific to each ailment, as well as those shared among them. We also identified high dose dietary zinc as a potential therapeutic agent and validated its efficacy in an acne mouse model.
Competing Interest Statement
All G.M.C COI are listed here: http://arep.med.harvard.edu/gmc/tech.html. All other authors report no conflict of interest.
Funding Statement
This work was supported by Leo Foundation (LF-OC-20-000420), Strategic Priority Research Program of The Chinese Academy of Sciences (XDB0480000) and National Institute of Health (R01AI141401).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Microarray and RNA-Seq studies published until July 2023, focusing on skin samples associated with Rosacea, Acne, and hidradenitis suppurativa, were sourced by querying the Gene Expression Omnibus (GEO) 21 using the following key words: (Acne OR Rosacea OR hidradenitis suppurativa OR HS) AND (RNA-seq OR Expression profiling OR high throughput sequencing)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All primary gene expression data are available from Gene Expression Omnibus. All analyzed results are available on Zenodo (8343604).
Abbreviations
- PPR
- Papulopastular Rosacea
- HS
- Hidradenitis Suppurativa
- DEG
- Differentially Expressed Gene
- GSEA
- Gene Set Enrichment Analysis
